2022.4 ～ 2023.3

【学術論文】

Tamura H, Kobashi K, Nishioka K, Yoshimura T, Hashimoto T, Shimizu S, Ito YM, Maeda Y, Sasaki M, Yamamoto K, Tamamura H, Aoyama H, Shirato H: Dosimetric advantages of daily adaptive strategy
in IMPT for high-risk prostate cancer.J Appl Clin Med Phys. 2022 Apr;23(4):e13531.
doi: 10.1002/acm2.13531. Epub 2022 Jan 19. PMID: 35045211

Uchinami Y, Katoh N, Suzuki R, Kanehira T, Tamura M, Takao S, Matsuura T, Miyamoto N, Fujita Y, Koizumi F, Taguchi H, Yasuda K, Nishioka K, Yokota I, Kobashi K, Aoyama H: A study on predicting cases that would benefit from proton beam therapy in primary liver tumors of less than or equal to 5 cm based on the estimated incidence of hepatic toxicity. Clin Transl Radiat Oncol. 2022 May 17; 35:70-75. doi: 10.1016/j.ctro.2022.05.004. eCollection 2022 Jul. PMID: 35633653

Hashimoto T: In reply to “Comment on “Particle therapy using protons or carbon ions for cancer patients with cardiac implantable electronic devices (CIED): a retrospective multi-institutional study””.Jpn J Radiol. 2022 May;40(5):544-545. doi: 10.1007/s11604-022-01253-6. PMID: 35182314.
Epub 2022 Feb 19

Nakano T, Aoyama H, Onodera S, Igaki H, Matsumoto Y, Kanemoto A, Shimamoto S, Matsuo M,
Tanaka H, Oya N, Matsuyama T, Ohta A, Maruyama K, Tanaka T, Kitamra N, Akazawa K, Maebayashi K: Japanese Radiation Oncology Study Group 13-1 (JROSG13-1) Investigators. Reduced- dose WBRT combined with SRS for 1-4 brain metastases aiming at minimizing neurocognitive function deterioration without compromising brain tumor control. Clin Transl Radiat Oncol.2022Sep 27;37:116-129. doi: 10.1016/j.ctro.2022.09.005. eCollection 2022 Nov. PMID: 36199814

Yamaguchi S, Okamoto M, Ishi Y, Sawaya R, Motegi H, Sugiyama M, Harada T, Fujima N, Mori T, Hashimoto T, Takakuwa E, Manabe A, Kudo K, Aoyama H, Fujimura M: Long-term consequences of residual lesions after chemoradiotherapy in patients with germinoma at onset. J Neurosurg Pediatr. 2022 Sep 9:1-8. doi: 10.3171/2022.8. PEDS 22301. PMID: 36087334

Sperduto PW, De B, Li J, Carpenter D, Kirkpatrick J, Milligan M, Shih HA, Kutuk T, Kotecha R, Higaki H, Otsuka M, Aoyama H, Bourgoin M, Roberge D, Dajani S, Sachdev S, Gainey J, Buatti JM, Breen W,
Brown PD, Ni L, Braunstein S, Gallitto M, Wang TJC, Shanley R, Lou E, Shiao J, Gaspar LE, Tanabe S, Nakano T, An Y, Chiang V, Zeng L, Soliman H, Elhalawani H, Cagney D, Thomas E, Boggs DH,
Ahluwalia MS, Mehta MP : Graded Prognostic Assessment (GPA) for Patients With Lung Cancer and Brain Metastases: Initial Report of the Small Cell Lung Cancer GPA and Update of the Non-Small Cell Lung Cancer GPA Including the Effect of Programmed Death Ligand 1 and Other Prognostic Factors. Int J Radiat Oncol Biol Phys. 2022 Sep 1;114(1):60-74. doi: 10.1016/j.ijrobp.2022.03.020. Epub 2022 Mar 21. PMID: 35331827

Yamazaki H, Kimoto T, Suzuki M, Murakami M, Suzuki O, Takagi M, Katoh N, Arimura T, Ogino T,
Ogino H : Particle Beam Therapy for Intrahepatic and Extrahepatic Biliary Duct Carcinoma:
A Multi-Institutional Retrospective Data Analysis. Cancers (Basel). 2022 Nov 28;14(23):5864. doi:10.3390/cancers14235864. PMID: 36497346

Kasamatsu K, Matsuura T, Yasuda K, Miyazaki K, Takao S, Tamura M, Otsuka M, Uchinami Y,
Aoyama H : Hyperfractionated intensity-modulated proton therapy for pharyngeal cancer with variable relative biological effectiveness: A simulation study. Med Phys. 2022 Dec;49(12):7815-7825. doi: 10.1002/mp.16064. Epub 2022 Nov 9. PMID: 36300598

Mizuno N, Okamoto H, Minemura T, Kawamura S, Tohyama N, Kurooka M, Kawamorita R,
Nakamura M, Ito Y, Shioyama Y, Aoyama H, Igaki H : Establishing quality indicators to comprehensively assess quality assurance and patient safety in radiotherapy and their relationship with an institution’s background. Radiother Oncol. 2022 Dec 24;179: 109452. doi: 10.1016/j.radonc.2022.109452.
PMID: 36572282

Yoshimura T, Nishioka K, Hashimoto T, Mori T, Kogame S, Seki K, Sugimori H, Yamashina H, Nomura Y, Kato F, Kudo K, Shimizu S, Aoyama H : Prostatic urinary tract visualization with super-resolution deep learning models. PLoS One. 2023 Jan 6;18(1) : e0280076. doi: 10.1371/journal.pone.0280076. eCollection 2023. PMID: 36607999

Uchinami Y, Kanehira T, Fujita Y, Miyamoto N, Yokokawa K, Koizumi F, Shido M, Takahashi S, Otsuka M, Yasuda K, Taguchi H, Nakazato K, Kobashi K, Katoh N, Aoyama H : Evaluation of short-term gastrointestinal motion and its impact on dosimetric parameters in stereotactic body radiation therapy for pancreatic cancer. Clin Transl Radiat Oncol. 2023 Jan 7; 39:100576. doi: 10.1016/j.ctro.2023.100576. eCollection 2023 Mar. PMID: 36686564

Kawamura H, Nakamura K, Yoshioka Y, Itasaka S, Tomita N, Onishi M, Iwata H, Aizawa T, Kikuchi K, Nagata K, Nakamura K, Nishioka K, Ishiyama H, Ueno S, Kokubo M, Yamazaki H, Watanabe K,
Toyoda T, Akimoto T; JROSG Working Subgroup of Urologic Oncology : Radiotherapy for ductal carcinoma of the prostate: an analysis based on the Japanese radiation oncology study group survey.
Jpn J Clin Oncol. 2023 Jan 28;53(2):146-152. doi: 10.1093/jjco/hyac180. PMID: 36478251

Miyazaki K, Fujii Y, Yamada T, Kanehira T, Miyamoto N, Matsuura T, Yasuda K, Uchinami Y, Otsuka M, Aoyama H, Takao S : Deformed dose restoration to account for tumor deformation and position changes for adaptive proton therapy. Med Phys. 2023 Feb;50(2):675-687. doi: 10.1002/mp.16149.
Epub 2022 Dec 29. PMID: 36502527

Asano S, Oseki K, Takao S, Miyazaki K, Yokokawa K, Matsuura T, Taguchi H, Katoh N, Aoyama H, Umegaki K, Miyamoto N : Technical note: Performance evaluation of volumetric imaging based on motion modeling by principal component analysis. Med Phys. 2023 Feb;50(2):993-999. doi: 10.1002/mp.16123. Epub 2022 Dec 3. PMID: 36427355

Uchinami Y, Katoh N, Abo D, Morita R, Taguchi H, Fujita Y, Kanehira T, Suzuki R, Miyamoto N, Takao S, Matsuura T, Sho T, Ogawa K, Orimo T, Kakisaka T, Kobashi K, Aoyama H : Study of hepatic toxicity in small liver tumors after photon or proton therapy based on factors predicting the benefits of proton.
Br J Radiol. 2023 Mar 1;96(1144):20220720. doi: 10.1259/bjr.20220720. Epub 2023 Jan 23.
PMID: 36633335

Higaki H, Nishioka K, Otsuka M, Nishikawa N, Shido M, Minatogawa H, Nishikawa Y, Takashina R, Hashimoto T, Katoh N, Taguchi H, Kinoshita R, Yasuda K, Mori T, Uchinami Y, Koizumi F, Fujita Y, Takahashi S, Hattori T, Nishiyama N, Aoyama H : Brain metastases in Japanese NSCLC patients: prognostic assessment and the use of osimertinib and immune checkpoint inhibitors-retrospective study. Radiat Oncol. 2023 Feb 7;18(1):25. doi: 10.1186/s13014-023-02218-3. PMID: 36750899

Otsuka M, Yasuda K, Uchinami Y, Tsushima N, Suzuki T, Kano S, Suzuki R, Miyamoto N, Minatogawa H, Dekura Y, Mori T, Nishioka K, Taguchi J, Shimizu Y, Katoh N, Homma A, Aoyama H : Detailed analysis of failure patterns using deformable image registration in hypopharyngeal cancer patients treated with sequential boost intensity-modulated radiotherapy. J Med Imaging Radiat Oncol. 2023 Feb;67(1):98-110. doi: 10.1111/1754-9485.13491. Epub 2022 Nov 14. PMID: 36373823

Kinoshita R, Mitamura T, Kato F, Hattori T, Higaki H, Takahashi S, Fujita Y, Otsuka M, Koizumi F, Uchinami Y, Mori T, Nishioka K, Hashimoto T, Ito YM, Watari H, Aoyama H : Distribution of human papilloma virus genotypes and treatment outcomes in definitive radiotherapy for cervical cancer.
J Radiat Res. 2023 Mar 23;64(2):463-470. doi: 10.1093/jrr/rrac086. PMID: 36596754

 

【総説・著書・その他】

Ishii R, Ohkoshi A, Kiyota N, Matsuura K, Yasuda K, Imamura Y, Saito Y, Homma A; Japan Clinical Oncology Group (JCOG) Head and Neck Cancer Study Group : Management of elderly patients with head and neck cancer. Jpn J Clin Oncol. 2022 Apr 6;52(4):313-321. doi: 10.1093/jjco/hyac013.
PMID: 35165732

Saito Y, Homma A, Kiyota N, Tahara M, Hanai N, Asakage T, Matsuura K, Ota I, Yokota T, Sano D, Kodaira T, Motegi A, Yasuda K, Takahashi S, Tanaka K, Onoe T, Okano S, Imamura Y, Ariizumi Y,
Hayashi R. Human papillomavirus-related oropharyngeal carcinoma. Jpn J Clin Oncol. 2022 Jul 8;52(7):692-698. doi: 10.1093/jjco/hyac049. PMID: 35383359.

Imamura Y, Kiyota N, Tahara M, Hanai N, Asakage T, Matsuura K, Ota I, Saito Y, Sano D, Kodaira T, Motegi A, Yasuda K, Takahashi S, Yokota T, Okano S, Tanaka K, Onoe T, Ariizumi Y, Homma A: Systemic therapy for salivary gland malignancy: current status and future perspectives. Jpn J Clin Oncol. 2022 Apr 6;52(4):293-302. doi: 10.1093/jjco/hyac008. PMID: 35134985.

 

【学会発表】（国際学会）

―ポスター発表―

K. Nishioka, T. Hashimoto, T. Mori, Y. Uchinami, R. Kinoshita, N. Katoh, H. Taguchi, K. Yasuda,
S.Takahashi, Y.M. Ito, S. Takao, M. Tamura, S. Shimizu, H. Shirato, and H. Aoyama : A Single-Institution Prospective Study to Evaluate the Safety and Efficacy of Real-Time-Image Gated Spot-Scanning Proton Therapy (RGPT) for Prostate Cancer. American Society for Radiation Oncology (ASTRO)64th Annual Meeting Oct 23-26,2022 San Antonio, TX/Web

H.Higaki, K. Nishioka, M. Otsuka, T. Hashimoto, N. Katoh, H. Taguchi, R. Kinoshita, K. Yasuda, T. Mori, Y. Uchinami, N. Nishikawa, M. Shido, F. Koizumi, Y. Fujita, S. Takahashi, T. Hattori, H. Minatogawa, R. Takashina, N. Nishiyama, H. Aoyama : Brain Metastases in Japanese NSCLC Patients: Prognostic Assessment and the Use of Osimertinib and Immune Checkpoint Inhibitors.American Society for Radiation Oncology(ASTRO)64th Annual Meeting Oct 23-26,2022 San Antonio,TX/Web

Uchinami Y, Katoh N, Suzuki R, Kanehira T, Takao S, Taguchi H, Kobashi K, Yokota I, Aoyama H. Factors predicting benefits of proton therapy in liver tumors of ≤5cm based on the hepatic toxicity. ESTRO 2022 Annual Meeting, Copenhagen, Denmark, 2022.5.6-10.